Johns Hopkins University (JHU) - SciVal Experts v3.6

220 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications for this application is PubMed, so only PubMed publications are included.

Select All |

Export to Endnote

1.
2013

Tim N Mak; Shu-Han Yu; Angelo M De Marzo; Holger Brüggemann; Karen S Sfanos

Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens.
The Prostate 2013;73(7):770-7.
2.
2013

Tamara L Lotan; Berrak Gumuskaya; Hameed Rahimi; Jessica L Hicks; Tsuyoshi Iwata; Brian D Robinson; Jonathan I Epstein; Angelo M De Marzo

Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(4):587-603.
3.
2013

Gang Zheng; Guido Martignoni; Cristina Antonescu; Elizabeth Montgomery; Charles Eberhart; George Netto; Janis Taube; William Westra; Jonathan I Epstein; Tamara Lotan; et al.

A broad survey of cathepsin K immunoreactivity in human neoplasms.
American journal of clinical pathology 2013;139(2):151-9.
4.
2012

Emmanuel S Antonarakis; Daniel Keizman; Zhe Zhang; Bora Gurel; Tamara L Lotan; Jessica L Hicks; Helen L Fedor; Michael A Carducci; Angelo M De Marzo; Mario A Eisenberger

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.
Cancer 2012;118(24):6063-71.
5.
2012

Alcides Chaux; Sarah B Peskoe; Nilda Gonzalez-Roibon; Luciana Schultz; Roula Albadine; Jessica Hicks; Angelo M De Marzo; Elizabeth A Platz; George J Netto

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(11):1543-9.
6.
2012

Antoun Toubaji; Siobhan Sutcliffe; Alcides Chaux; Kristen Lecksell; Jessica Hicks; Angelo M De Marzo; Elizabeth A Platz; George J Netto

Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.
Human pathology 2012;43(11):1852-65.
7.
2012

Paul J Dluzniewski; Ming-Hsi Wang; Siqun Lilly Zheng; Angelo M De Marzo; Charles G Drake; Helen L Fedor; Alan W Partin; Misop Han; M Daniele Fallin; Jianfeng Xu; et al.

Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1774-82.
8.
2012

Siobhan Sutcliffe; Cathee Till; Charlotte A Gaydos; Frank J Jenkins; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; William G Nelson; et al.

Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer causes & control : CCC 2012;23(9):1511-8.
9.
2012

Laxmi G Pellakuru; Tsuyoshi Iwata; Bora Gurel; Denise Schultz; Jessica Hicks; Carlise Bethel; Srinivasan Yegnasubramanian; Angelo M De Marzo

Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.
The American journal of pathology 2012;181(2):560-9.
10.
2012

Ashley Cimino-Mathews; Jessica L Hicks; Peter B Illei; Marc K Halushka; John H Fetting; Angelo M De Marzo; Ben Ho Park; Pedram Argani

Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy.
Human pathology 2012;43(7):1003-11.
11.
2012

Samuel R Denmeade; Annastasiah M Mhaka; D Marc Rosen; W Nathaniel Brennen; Susan Dalrymple; Ingrid Dach; Claus Olesen; Bora Gurel; Angelo M Demarzo; George Wilding; et al.

Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.
Science translational medicine 2012;4(140):140ra86.
12.
2012

A P Chokkalingam; E D Yeboah; A Demarzo; G Netto; K Yu; R B Biritwum; Y Tettey; A Adjei; S Jadallah; Y Li; et al.

Prevalence of BPH and lower urinary tract symptoms in West Africans.
Prostate cancer and prostatic diseases 2012;15(2):170-6.
13.
2012

Thomas A Dunn; Helen L Fedor; Angelo M De Marzo; Jun Luo

Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.
Asian journal of andrology 2012;14(3):385-92.
14.
2012

M Uemura; Q Zheng; C M Koh; W G Nelson; S Yegnasubramanian; A M De Marzo

Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation.
Oncogene 2012;31(10):1254-63.
15.
2012

Aatur D Singhi; Ashley Cimino-Mathews; Robert B Jenkins; Fusheng Lan; Stephanie R Fink; Hind Nassar; Russell Vang; John H Fetting; Jessica Hicks; Saraswati Sukumar; et al.

MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(3):378-87.
16.
2012

William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian

USP2a activation of MYC in prostate cancer.
Cancer discovery 2012;2(3):206-7.
17.
2012

Karen S Sfanos; Amanda L Aloia; Angelo M De Marzo; Alan Rein

XMRV and prostate cancer--a 'final' perspective.
Nature reviews. Urology 2012;9(2):111-8.
18.
2012

Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; et al.

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
The American journal of surgical pathology 2012;36(2):173-84.
19.
2012

Karen S Sfanos; Angelo M De Marzo

Prostate cancer and inflammation: the evidence.
Histopathology 2012;60(1):199-215.
20.
2012

Joseph P Garay; Bedri Karakas; Abde M Abukhdeir; David P Cosgrove; John P Gustin; Michaela J Higgins; Hiroyuki Konishi; Yuko Konishi; Josh Lauring; Morassa Mohseni; et al.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.
Breast cancer research : BCR 2012;14(1):R27.
21.
2011

Susmita Ghosh; Hiu Lau; Brian W Simons; Jonathan D Powell; David J Meyers; Angelo M De Marzo; David M Berman; Tamara L Lotan

PI3K/mTOR signaling regulates prostatic branching morphogenesis.
Developmental biology 2011;360(2):329-42.
22.
2011

Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; et al.

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9 Suppl 5():S1-32; quiz S33.
23.
2011

Antoun Toubaji; Roula Albadine; Alan K Meeker; William B Isaacs; Tamara Lotan; Michael C Haffner; Alcides Chaux; Jonathan I Epstein; Misop Han; Patrick C Walsh; et al.

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(11):1511-20.
24.
2011

Tamara L Lotan; Bora Gurel; Siobhan Sutcliffe; David Esopi; Wennuan Liu; Jianfeng Xu; Jessica L Hicks; Ben H Park; Elizabeth Humphreys; Alan W Partin; et al.

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6563-73.
25.
2011

Zhewei Zhang; Zhiming Yang; Sari Jäämaa; Hester Liu; Laxmi G Pellakuru; Tsuyoshi Iwata; Taija M af Hällström; Angelo M De Marzo; Marikki Laiho

Differential epithelium DNA damage response to ATM and DNA-PK pathway inhibition in human prostate tissue culture.
Cell cycle (Georgetown, Tex.) 2011;10(20):3545-53.
26.
2011

Luciana Schultz; Alcides Chaux; Roula Albadine; Jessica Hicks; Jenny J Kim; Angelo M De Marzo; Mohamad E Allaf; Michael A Carducci; Ronald Rodriguez; Hans-Joerg Hammers; et al.

Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.
The American journal of surgical pathology 2011;35(10):1549-56.
27.
2011

Christopher M Heaphy; Andrea P Subhawong; Seung-Mo Hong; Michael G Goggins; Elizabeth A Montgomery; Edward Gabrielson; George J Netto; Jonathan I Epstein; Tamara L Lotan; William H Westra; et al.

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
The American journal of pathology 2011;179(4):1608-15.
28.
2011

Cheryl M Koh; Tsuyoshi Iwata; Qizhi Zheng; Carlise Bethel; Srinivasan Yegnasubramanian; Angelo M De Marzo

Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
Oncotarget 2011;2(9):669-83.
29.
2011

S Sutcliffe; R L Nevin; R Pakpahan; D J Elliott; S R Cole; A M De Marzo; C A Gaydos; W B Isaacs; W G Nelson; L J Sokoll; et al.

Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.
British journal of cancer 2011;105(5):602-5.
30.
2011

Michael C Haffner; Alcides Chaux; Alan K Meeker; David M Esopi; Jonathan Gerber; Laxmi G Pellakuru; Antoun Toubaji; Pedram Argani; Christine Iacobuzio-Donahue; William G Nelson; et al.

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
Oncotarget 2011;2(8):627-37.
31.
2011

Francis Buadi; Ann W Hsing; Jerry A Katzmann; Ruth M Pfeiffer; Adam Waxman; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew Adjei; Lisa W Chu; et al.

High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
American journal of hematology 2011;86(7):554-8.
32.
2011

Alcides Chaux; Roula Albadine; Antoun Toubaji; Jessica Hicks; Alan Meeker; Elizabeth A Platz; Angelo M De Marzo; George J Netto

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.
The American journal of surgical pathology 2011;35(7):1014-20.
33.
2011

Michael C Haffner; Angelo M De Marzo; Alan K Meeker; William G Nelson; Srinivasan Yegnasubramanian

Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(12):3858-64.
34.
2011

Tamara L Lotan; Nilesh S Gupta; Wenle Wang; Antoun Toubaji; Michael C Haffner; Alcides Chaux; Jessica L Hicks; Alan K Meeker; Charles J Bieberich; Angelo M De Marzo; et al.

ERG gene rearrangements are common in prostatic small cell carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(6):820-8.
35.
2011

Cheryl M Koh; Bora Gurel; Siobhan Sutcliffe; Martin J Aryee; Denise Schultz; Tsuyoshi Iwata; Motohide Uemura; Karen I Zeller; Uzoma Anele; Qizhi Zheng; et al.

Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.
The American journal of pathology 2011;178(4):1824-34.
36.
2011

Dilek Ertoy Baydar; Ibrahim Kulac; Bora Gurel; Angelo De Marzo

A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
International journal of surgical pathology 2011;19(1):131-6.
37.
2011

Srinivasan Yegnasubramanian; Zhijin Wu; Michael C Haffner; David Esopi; Martin J Aryee; Raghav Badrinath; Tony L He; James D Morgan; Benilton Carvalho; Qizhi Zheng; et al.

Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
BMC genomics 2011;12():313.
38.
2011

Karen Sandell Sfanos; Amanda L Aloia; Jessica L Hicks; David M Esopi; Jared P Steranka; Wei Shao; Silvia Sanchez-Martinez; Srinivasan Yegnasubramanian; Kathleen H Burns; Alan Rein; et al.

Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines.
PloS one 2011;6(6):e20874.
39.
2011

Matthew P Vaughn; Debika Biswal Shinohara; Nicole Castagna; Jessica L Hicks; George Netto; Angelo M De Marzo; Traci J Speed; Zachery R Reichert; Bernard Kwabi-Addo; Colin J Henderson; et al.

Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdose.
PloS one 2011;6(10):e25707.
40.
2011

Hongkai Ji; George Wu; Xiangcan Zhan; Alexandra Nolan; Cheryl Koh; Angelo De Marzo; Hoang Mai Doan; Jinshui Fan; Christopher Cheadle; Mohammad Fallahi; et al.

Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation.
PloS one 2011;6(10):e26057.
41.
2010

Amanda L Aloia; Karen S Sfanos; William B Isaacs; Qizhi Zheng; Frank Maldarelli; Angelo M De Marzo; Alan Rein

XMRV: a new virus in prostate cancer?
Cancer research 2010;70(24):10028-33.
42.
2010

Angelo M De Marzo; William G Nelson; Charles J Bieberich; Srinivasan Yegnasubramanian

Prostate cancer: New answers prompt new questions regarding cell of origin.
Nature reviews. Urology 2010;7(12):650-2.
43.
2010

Luciana Schultz; Roula Albadine; Jessica Hicks; Sana Jadallah; Angelo M DeMarzo; Ying-Bei Chen; Matthew E Nielsen; Matthew E Neilsen; Mark L Gonzalgo; David Sidransky; et al.

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
Cancer 2010;116(23):5517-26.
44.
2010

Sari Jäämaa; Taija M Af Hällström; Anna Sankila; Ville Rantanen; Hannu Koistinen; Ulf-Håkan Stenman; Zhewei Zhang; Zhiming Yang; Angelo M De Marzo; Kimmo Taari; et al.

DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue.
Cancer research 2010;70(21):8630-41.
45.
2010

H Chen; W Liu; W Roberts; S Hooker; H Fedor; A DeMarzo; W Isaacs; R A Kittles

8q24 allelic imbalance and MYC gene copy number in primary prostate cancer.
Prostate cancer and prostatic diseases 2010;13(3):238-43.
46.
2010

Pedram Argani; Jessica Hicks; Angelo M De Marzo; Roula Albadine; Peter B Illei; Marc Ladanyi; Victor E Reuter; George J Netto

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
The American journal of surgical pathology 2010;34(9):1295-303.
47.
2010

Bora Gurel; Tehmina Z Ali; Elizabeth A Montgomery; Shahnaz Begum; Jessica Hicks; Michael Goggins; Charles G Eberhart; Douglas P Clark; Charles J Bieberich; Jonathan I Epstein; et al.

NKX3.1 as a marker of prostatic origin in metastatic tumors.
The American journal of surgical pathology 2010;34(8):1097-105.
48.
2010

Michael C Haffner; Martin J Aryee; Antoun Toubaji; David M Esopi; Roula Albadine; Bora Gurel; William B Isaacs; G Steven Bova; Wennuan Liu; Jianfeng Xu; et al.

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
Nature genetics 2010;42(8):668-75.
49.
2010

Elizabeth A Platz; Siobhan Sutcliffe; Angelo M De Marzo; Charles G Drake; Nader Rifai; Ann W Hsing; Ashraful Hoque; Marian L Neuhouser; Phyllis J Goodman; Alan R Kristal

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.
Cancer causes & control : CCC 2010;21(6):847-51.
50.
2010

Donna E Hansel; Eric Platt; Mohammed Orloff; Jyoti Harwalker; Swathi Sethu; Jessica L Hicks; Angelo De Marzo; Roxanne E Steinle; Eric D Hsi; Dan Theodorescu; et al.

Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
The American journal of pathology 2010;176(6):3062-72.
51.
2010

Andrew J Armstrong; George J Netto; Michelle A Rudek; Susan Halabi; David P Wood; Patricia A Creel; Kelly Mundy; S Lindsay Davis; Ting Wang; Roula Albadine; et al.

A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):3057-66.
52.
2010

Cheryl M Koh; Charles J Bieberich; Chi V Dang; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo

MYC and Prostate Cancer.
Genes & cancer 2010;1(6):617-28.
53.
2010

Simon A Williams; Yi Xu; Angelo M De Marzo; John T Isaacs; Samuel R Denmeade

Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
The Prostate 2010;70(7):788-96.
54.
2010

Karen M Hill; Sara Kalifa; Jharna R Das; Tahira Bhatti; Martha Gay; Danielle Williams; Latonia Taliferro-Smith; Angelo M De Marzo

The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
The Prostate 2010;70(7):755-64.
55.
2010

Alison M Mondul; Elizabeth Selvin; Angelo M De Marzo; Stephen J Freedland; Elizabeth A Platz

Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.
Cancer causes & control : CCC 2010;21(5):671-8.
56.
2010

May Khalili; Laura N Mutton; Bora Gurel; Jessica L Hicks; Angelo M De Marzo; Charles J Bieberich

Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.
The American journal of pathology 2010;176(5):2259-68.
57.
2010

Siobhan Sutcliffe; Raphael P Viscidi; Cathee Till; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; Angelo M De Marzo; Elizabeth A Platz

Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):614-8.
58.
2010

Tsuyoshi Iwata; Denise Schultz; Jessica Hicks; Gretchen K Hubbard; Laura N Mutton; Tamara L Lotan; Carlise Bethel; Matthew T Lotz; Srinivasan Yegnasubramanian; William G Nelson; et al.

MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
PloS one 2010;5(2):e9427.
59.
2010

Donald J Vander Griend; Jason D'Antonio; Bora Gurel; Lizamma Antony; Angelo M Demarzo; John T Isaacs

Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
The Prostate 2010;70(1):90-9.
60.
2009

Roula Albadine; Mathieu Latour; Antoun Toubaji; Michael Haffner; William B Isaacs; Elizabeth A Platz; Alan K Meeker; Angelo M Demarzo; Jonathan I Epstein; George J Netto

TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(11):1415-22.
61.
2009

Karen S Sfanos; Tullia C Bruno; Alan K Meeker; Angelo M De Marzo; William B Isaacs; Charles G Drake

Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
The Prostate 2009;69(15):1694-703.
62.
2009

Emmanuel S Antonarakis; Elisabeth I Heath; Janet R Walczak; William G Nelson; Helen Fedor; Angelo M De Marzo; Marianna L Zahurak; Steven Piantadosi; Andrew J Dannenberg; Robin T Gurganus; et al.

Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):4986-93.
63.
2009

Donald J Vander Griend; Yuko Konishi; Angelo M De Marzo; John T Isaacs; Alan K Meeker

Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to Multispecies recombinant urogenital sinus xenografts.
The Prostate 2009;69(14):1557-64.
64.
2009

William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian

Epigenetic alterations in human prostate cancers.
Endocrinology 2009;150(9):3991-4002.
65.
2009

Aditya Bardia; Elizabeth A Platz; Srinivasan Yegnasubramanian; Angelo M De Marzo; William G Nelson

Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.
Current opinion in pharmacology 2009;9(4):419-26.
66.
2009

A Karim Kader; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Guifang Yan; Seong-Tae Kim; Helen Fedor; Angelo M DeMarzo; Jonathan I Epstein; Patrick C Walsh; et al.

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
The Prostate 2009;69(11):1195-205.
67.
2009

Kazutoshi Fujita; Christian P Pavlovich; George J Netto; Yuko Konishi; William B Isaacs; Syed Ali; Angelo De Marzo; Alan K Meeker

Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology.
Human pathology 2009;40(7):924-33.
68.
2009

Ming-Hsi Wang; Kathy J Helzlsouer; Michael W Smith; Judith A Hoffman-Bolton; Sandra L Clipp; Viktoriya Grinberg; Angelo M De Marzo; William B Isaacs; Charles G Drake; Yin Yao Shugart; et al.

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
The Prostate 2009;69(8):874-85.
69.
2009

Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; et al.

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.
Cancer research 2009;69(10):4309-18.
70.
2009

Siobhan Sutcliffe; John F Alderete; Cathee Till; Phyllis J Goodman; Ann W Hsing; Jonathan M Zenilman; Angelo M De Marzo; Elizabeth A Platz

Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
International journal of cancer. Journal international du cancer 2009;124(9):2082-7.
71.
2009

Donna E Hansel; Masashi Nakayama; Jun Luo; Abde M Abukhdeir; Ben H Park; Charles J Bieberich; Jessica L Hicks; Mario Eisenberger; William G Nelson; Jasek L Mostwin; et al.

Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
The Prostate 2009;69(6):603-9.
72.
2009

Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; et al.

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Nature 2009;458(7239):762-5.
73.
2009

J Kellogg Parsons; Elizabeth A Saria; Masashi Nakayama; Robert L Vessella; Charles L Sawyers; William B Isaacs; Dennis A Faith; G Steven Bova; Christina A Samathanam; Rebecca Mitchell; et al.

Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells.
The Prostate 2009;69(5):559-69.
74.
2009

Karen S Sfanos; Brice A Wilson; Angelo M De Marzo; William B Isaacs

Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(9):3443-8.
75.
2009

Tamara L Lotan; Antoun Toubaji; Roula Albadine; Mathieu Latour; Mehsati Herawi; Alan K Meeker; Angelo M DeMarzo; Elizabeth A Platz; Jonathan I Epstein; George J Netto

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(3):359-65.
76.
2009

Thomas A Dunn; Helen Fedor; William B Isaacs; Angelo M De Marzo; Jun Luo

Genome-wide expression analysis of recently processed formalin-fixed paraffin embedded human prostate tissues.
The Prostate 2009;69(2):214-8.
77.
2008

Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Cancer research 2008;68(23):9703-11.
78.
2008

Joshi J Alumkal; Zhe Zhang; Elizabeth B Humphreys; Christina Bennett; Leslie A Mangold; Michael A Carducci; Alan W Partin; Elizabeth Garrett-Mayer; Angelo M DeMarzo; James G Herman

Effect of DNA methylation on identification of aggressive prostate cancer.
Urology 2008;72(6):1234-9.
79.
2008

Srinivasan Yegnasubramanian; Michael C Haffner; Yonggang Zhang; Bora Gurel; Toby C Cornish; Zhijin Wu; Rafael A Irizarry; James Morgan; Jessica Hicks; Theodore L DeWeese; et al.

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
Cancer research 2008;68(21):8954-67.
80.
2008

Georges J Netto; Yasutomo Nakai; Masashi Nakayama; Sana Jadallah; Antoun Toubaji; Norio Nonomura; Roula Albadine; Jessica L Hicks; Jonathan I Epstein; Srinivasan Yegnasubramanian; et al.

Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(11):1337-44.
81.
2008

Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.
Advances in anatomic pathology 2008;15(6):319-31.
82.
2008

Shuanzeng Wei; Thomas A Dunn; William B Isaacs; Angelo M De Marzo; Jun Luo

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.
The Prostate 2008;68(13):1387-95.
83.
2008

Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Van Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; et al.

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1156-67.
84.
2008

Karen Sandell Sfanos; Tullia C Bruno; Charles H Maris; Lauren Xu; Christopher J Thoburn; Angelo M DeMarzo; Alan K Meeker; William B Isaacs; Charles G Drake

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3254-61.
85.
2008

Kazutoshi Fujita; Charles M Ewing; Lori J Sokoll; Debra J Elliott; Mark Cunningham; Angelo M De Marzo; William B Isaacs; Christian P Pavlovich

Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.
The Prostate 2008;68(8):872-82.
86.
2008

Andrew C Goodwin; Sana Jadallah; Antoun Toubaji; Kristen Lecksell; Jessica L Hicks; Jeanne Kowalski; G Steven Bova; Angelo M De Marzo; George J Netto; Robert A Casero

Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.
The Prostate 2008;68(7):766-72.
87.
2008

Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana W Molavi; M Evangeline Taylor; Wei Wen Teo; Constance Griffin; John Fetting; Nancy E Davidson; Angelo M De Marzo; et al.

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1938-46.
88.
2008

James I Geller; Pedram Argani; Adebowale Adeniran; Edith Hampton; Angelo De Marzo; Jessica Hicks; Margaret H Collins

Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Cancer 2008;112(7):1607-16.
89.
2008

Karen S Sfanos; Jurga Sauvageot; Helen L Fedor; James D Dick; Angelo M De Marzo; William B Isaacs

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.
The Prostate 2008;68(3):306-20.
90.
2008

Gitanjali I Bechan; Alan K Meeker; Angelo M De Marzo; Frederick Racke; Ronald Jaffe; Elizabeth Sugar; Robert J Arceci

Telomere length shortening in Langerhans cell histiocytosis.
British journal of haematology 2008;140(4):420-8.
91.
2008

Suresh Mathivanan; Mukhtar Ahmed; Natalie G Ahn; Hainard Alexandre; Ramars Amanchy; Philip C Andrews; Joel S Bader; Brian M Balgley; Marcus Bantscheff; Keiryn L Bennett; et al.

Human Proteinpedia enables sharing of human protein data.
Nature biotechnology 2008;26(2):164-7.
92.
2008

Abde M Abukhdeir; Michele I Vitolo; Pedram Argani; Angelo M De Marzo; Bedri Karakas; Hiroyuki Konishi; John P Gustin; Josh Lauring; Joseph P Garay; Courtney Pendleton; et al.

Tamoxifen-stimulated growth of breast cancer due to p21 loss.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(1):288-93.
93.
2008

Ni Wayan Winarti; Pedram Argani; Angelo M De Marzo; Jessica Hicks; Ketut Mulyadi

Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
International journal of surgical pathology 2008;16(1):66-72.
94.
2008

Dengfeng Cao; Kornelia Polyak; Marc K Halushka; Hind Nassar; Nina Kouprina; Christine Iacobuzio-Donahue; Xinyan Wu; Saraswati Sukumar; Jessica Hicks; Angelo De Marzo; et al.

Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Breast cancer research : BCR 2008;10(5):R91.
95.
2007

Siobhan Sutcliffe; Sabine Rohrmann; Edward Giovannucci; Kenrad E Nelson; Angelo M De Marzo; William B Isaacs; William G Nelson; Elizabeth A Platz

Viral infections and lower urinary tract symptoms in the third national health and nutrition examination survey.
The Journal of urology 2007;178(5):2181-5.
96.
2007

Joseph F Grosso; Cristin C Kelleher; Timothy J Harris; Charles H Maris; Edward L Hipkiss; Angelo De Marzo; Robert Anders; George Netto; Derese Getnet; Tullia C Bruno; et al.

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
The Journal of clinical investigation 2007;117(11):3383-92.
97.
2007

Angelo M De Marzo; Yasutomo Nakai; William G Nelson

Inflammation, atrophy, and prostate carcinogenesis.
Urologic oncology 2007;25(5):398-400.
98.
2007

Pedram Argani; Semra Olgac; Satish K Tickoo; Michael Goldfischer; Holger Moch; David Y Chan; John N Eble; Stephen M Bonsib; Mireya Jimeno; Josep Lloreta; et al.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
The American journal of surgical pathology 2007;31(8):1149-60.
99.
2007

Ai-Ying Chuang; Angelo M DeMarzo; Robert W Veltri; Rajni B Sharma; Charles J Bieberich; Jonathan I Epstein

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
The American journal of surgical pathology 2007;31(8):1246-55.
100.
2007

Siobhan Sutcliffe; Edward Giovannucci; Charlotte A Gaydos; Raphael P Viscidi; Frank J Jenkins; Jonathan M Zenilman; Lisa P Jacobson; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz

Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(8):1573-80.
101.
2007

Soroush Rais-Bahrami; Joseph J Drabick; Angelo M De Marzo; Jessica Hicks; Clement Ho; Alan E Caroe; Pedram Argani

Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.
Urology 2007;70(1):178.e3-6.
102.
2007

Sven Perner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Angelo M De Marzo; et al.

TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
The American journal of surgical pathology 2007;31(6):882-8.
103.
2007

D E Hansel; A M DeMarzo; E A Platz; S Jadallah; J Hicks; J I Epstein; A W Partin; G J Netto

Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
The Journal of urology 2007;177(5):1736-40.
104.
2007

Agoston T Agoston; Pedram Argani; Angelo M De Marzo; Jessica L Hicks; William G Nelson

Retinoblastoma pathway dysregulation causes DNA methyltransferase 1 overexpression in cancer via MAD2-mediated inhibition of the anaphase-promoting complex.
The American journal of pathology 2007;170(5):1585-93.
105.
2007

Sueli Suzigan; Ricardo Drut; Paulo Faria; Pedram Argani; Angelo M De Marzo; Rui Nogueira Barbosa; Eliseu Roberto Mello Denadai; Júlio Martins-Filho; Rubens Carlos Martucci; Tufik Bauab

Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.
International journal of surgical pathology 2007;15(2):199-203.
106.
2007

Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson

Inflammation in prostate carcinogenesis.
Nature reviews. Cancer 2007;7(4):256-69.
107.
2007

Yasutomo Nakai; William G Nelson; Angelo M De Marzo

The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.
Cancer research 2007;67(3):1378-84.
108.
2007

Gary J Kelloff; Daniel C Sullivan; Houston Baker; Lawrence P Clarke; Robert Nordstrom; James L Tatum; Gary S Dorfman; Paula Jacobs; Christine D Berg; Martin G Pomper; et al.

Workshop on imaging science development for cancer prevention and preemption.
Cancer biomarkers : section A of Disease markers 2007;3(1):1-33.
109.
2007

Sushant K Kachhap; Dennis Faith; David Z Qian; Shabana Shabbeer; Nathan L Galloway; Roberto Pili; Samuel R Denmeade; Angelo M DeMarzo; Michael A Carducci

The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.
PloS one 2007;2(9):e844.
110.
2007

William G Nelson; Srinivasan Yegnasubramanian; Agoston T Agoston; Patrick J Bastian; Byron H Lee; Masashi Nakayama; Angelo M De Marzo

Abnormal DNA methylation, epigenetics, and prostate cancer.
Frontiers in bioscience : a journal and virtual library 2007;12():4254-66.
111.
2007

Mehsati Herawi; Angelo M De Marzo; Glen Kristiansen; Jonathan I Epstein

Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.
Human pathology 2007;38(1):72-8.
112.
2006

Samson W Fine; Pedram Argani; Angelo M DeMarzo; Brett Delahunt; Thomas J Sebo; Victor E Reuter; Jonathan I Epstein

Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney.
The American journal of surgical pathology 2006;30(12):1554-60.
113.
2006

Carlise R Bethel; Dennis Faith; Xiang Li; Bin Guan; Jessica L Hicks; Fusheng Lan; Robert B Jenkins; Charles J Bieberich; Angelo M De Marzo

Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Cancer research 2006;66(22):10683-90.
114.
2006

Siobhan Sutcliffe; Edward Giovannucci; Angelo M De Marzo; Michael F Leitzmann; Walter C Willett; Elizabeth A Platz

Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(11):2160-6.
115.
2006

Thomas A Dunn; Shenglin Chen; Dennis A Faith; Jessica L Hicks; Elizabeth A Platz; Yidong Chen; Charles M Ewing; Jurga Sauvageot; William B Isaacs; Angelo M De Marzo; et al.

A novel role of myosin VI in human prostate cancer.
The American journal of pathology 2006;169(5):1843-54.
116.
2006

Ivan V Litvinov; Donald J Vander Griend; Lizamma Antony; Susan Dalrymple; Angelo M De Marzo; Charles G Drake; John T Isaacs

Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(41):15085-90.
117.
2006

Anil V Parwani; Cameron Marlow; Angelo M Demarzo; Stephen D Mikolajczyk; Harry G Rittenhouse; Robert W Veltri; Theresa Y Chan

Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
The American journal of surgical pathology 2006;30(10):1231-6.
118.
2006

Angelo M De Marzo; Elizabeth A Platz; Jonathan I Epstein; Tehmina Ali; Anthanase Billis; Teresa Y Chan; Liang Cheng; Milton Datta; Lars Egevad; Dilek Ertoy-Baydar; et al.

A working group classification of focal prostate atrophy lesions.
The American journal of surgical pathology 2006;30(10):1281-91.
119.
2006

B Karakas; A Weeraratna; A Abukhdeir; B G Blair; H Konishi; S Arena; K Becker; W Wood; P Argani; A M De Marzo; et al.

Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells.
Oncogene 2006;25(40):5561-9.
120.
2006

Ganesh S Palapattu; Alan Meeker; Timothy Harris; Michael I Collector; Saul J Sharkis; Angelo M DeMarzo; Christopher Warlick; Charles G Drake; William G Nelson

Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium.
The Journal of urology 2006;176(2):813-8.
121.
2006

Donna E Hansel; Alan K Meeker; Jessica Hicks; Angelo M De Marzo; Keith D Lillemoe; Richard Schulick; Ralph H Hruban; Anirban Maitra; Pedram Argani

Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(6):772-9.
122.
2006

Siobhan Sutcliffe; Jonathan M Zenilman; Khalil G Ghanem; Rosemary A Jadack; Lori J Sokoll; Debra J Elliott; William G Nelson; Angelo M De Marzo; Stephen R Cole; William B Isaacs; et al.

Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration.
The Journal of urology 2006;175(5):1937-42.
123.
2006

Siobhan Sutcliffe; Edward Giovannucci; John F Alderete; Te-Hung Chang; Charlotte A Gaydos; Jonathan M Zenilman; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz

Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):939-45.
124.
2006

Srinivasan Yegnasubramanian; Xiaohui Lin; Michael C Haffner; Angelo M DeMarzo; William G Nelson

Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation.
Nucleic acids research 2006;34(3):e19.
125.
2005

Siobhan Sutcliffe; Edward Giovannucci; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz

Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms.
American journal of epidemiology 2005;162(9):898-906.
126.
2005

Susan Dalrymple; Lizamma Antony; Yi Xu; Aarti R Uzgare; Julia T Arnold; Jurga Savaugeot; Lori J Sokoll; Angelo M De Marzo; John T Isaacs

Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
Cancer research 2005;65(20):9269-79.
127.
2005

Michiel S van der Heijden; Jonathan R Brody; David A Dezentje; Eike Gallmeier; Steven C Cunningham; Michael J Swartz; Angelo M DeMarzo; G Johan A Offerhaus; William H Isacoff; Ralph H Hruban; et al.

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7508-15.
128.
2005

Dennis Faith; Steven Han; Daniel K Lee; Andreas Friedl; Jessica L Hicks; Angelo M De Marzo; David F Jarrard

p16 Is upregulated in proliferative inflammatory atrophy of the prostate.
The Prostate 2005;65(1):73-82.
129.
2005

Ganesh S Palapattu; Siobhan Sutcliffe; Patrick J Bastian; Elizabeth A Platz; Angelo M De Marzo; William B Isaacs; William G Nelson

Prostate carcinogenesis and inflammation: emerging insights.
Carcinogenesis 2005;26(7):1170-81.
130.
2005

Shan Zha; Sacha Ferdinandusse; Jessica L Hicks; Simone Denis; Thomas A Dunn; Ronald J Wanders; Jun Luo; Angelo M De Marzo; William B Isaacs

Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
The Prostate 2005;63(4):316-23.
131.
2005

Agoston T Agoston; Pedram Argani; Srinivasan Yegnasubramanian; Angelo M De Marzo; Mohammad Ali Ansari-Lari; Jessica L Hicks; Nancy E Davidson; William G Nelson

Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
The Journal of biological chemistry 2005;280(18):18302-10.
132.
2005

Elizabeth A Platz; Sabine Rohrmann; Jay D Pearson; Maria M Corrada; Douglas J Watson; Angelo M De Marzo; Patricia K Landis; E Jeffrey Metter; H Ballentine Carter

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):390-6.
133.
2005

Helen L Fedor; Angelo M De Marzo

Practical methods for tissue microarray construction.
Methods in molecular medicine 2005;103():89-101.
134.
2005

Sabine Rohrmann; Angelo M De Marzo; Ellen Smit; Edward Giovannucci; Elizabeth A Platz

Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III).
The Prostate 2005;62(1):27-33.
135.
2004

Patrick J Bastian; Srinivasan Yegnasubramanian; Ganesh S Palapattu; Craig G Rogers; Xiaohui Lin; Angelo M De Marzo; William G Nelson

Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
European urology 2004;46(6):698-708.
136.
2004

Shan Zha; Vasan Yegnasubramanian; William G Nelson; William B Isaacs; Angelo M De Marzo

Cyclooxygenases in cancer: progress and perspective.
Cancer letters 2004;215(1):1-20.
137.
2004

William G Nelson; Angelo M De Marzo; Theodore L DeWeese; William B Isaacs

The role of inflammation in the pathogenesis of prostate cancer.
The Journal of urology 2004;172(5 Pt 2):S6-11; discussion S11-2.
138.
2004

Dennis A Faith; William B Isaacs; James D Morgan; Helen L Fedor; Jessica L Hicks; Leslie A Mangold; Patrick C Walsh; Alan W Partin; Elizabeth A Platz; Jun Luo; et al.

Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
The Prostate 2004;61(3):215-27.
139.
2004

Craig G Rogers; Gai Yan; Shan Zha; Mark L Gonzalgo; William B Isaacs; Jun Luo; Angelo M De Marzo; William G Nelson; Christian P Pavlovich

Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.
The Journal of urology 2004;172(4 Pt 1):1501-3.
140.
2004

Leonard S Marks; Munekado Kojima; Angelo Demarzo; David Heber; David G Bostwick; Junqi Qian; Frederick J Dorey; Robert W Veltri; James L Mohler; Alan W Partin

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue.
Urology 2004;64(4):765-71.
141.
2004

Gloria L David; Srinivasan Yegnasubramanian; Arunima Kumar; Valerie L Marchi; Angelo M De Marzo; Xiaohui Lin; William G Nelson

MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
Cancer biology & therapy 2004;3(6):540-8.
142.
2004

Elizabeth A Platz; Angelo M De Marzo; Thomas P Erlinger; Nader Rifai; Kala Visvanathan; Sandra C Hoffman; Kathy J Helzlsouer

No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
The Prostate 2004;59(4):393-400.
143.
2004

Alan K Meeker; Jessica L Hicks; Christine A Iacobuzio-Donahue; Elizabeth A Montgomery; William H Westra; Theresa Y Chan; Brigitte M Ronnett; Angelo M De Marzo

Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3317-26.
144.
2004

Elizabeth Montgomery; Pedram Argani; Jessica L Hicks; Angelo M DeMarzo; Alan K Meeker

Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
The American journal of pathology 2004;164(5):1523-9.
145.
2004

P J Bastian; M Nakayama; A M De Marzo; W G Nelson

[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].
Der Urologe. Ausg. A 2004;43(5):573-9.
146.
2004

Srinivasan Yegnasubramanian; Jeanne Kowalski; Mark L Gonzalgo; Marianna Zahurak; Steven Piantadosi; Patrick C Walsh; G Steven Bova; Angelo M De Marzo; William B Isaacs; William G Nelson

Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Cancer research 2004;64(6):1975-86.
147.
2004

Mark A Rubin; Angelo M De Marzo

Molecular genetics of human prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):380-8.
148.
2004

Alan K Meeker; Jessica L Hicks; Edward Gabrielson; William M Strauss; Angelo M De Marzo; Pedram Argani

Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma.
The American journal of pathology 2004;164(3):925-35.
149.
2004

Angelo M De Marzo; Theodore L DeWeese; Elizabeth A Platz; Alan K Meeker; Masashi Nakayama; Jonathan I Epstein; William B Isaacs; William G Nelson

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment.
Journal of cellular biochemistry 2004;91(3):459-77.
150.
2004

Masashi Nakayama; Mark L Gonzalgo; Srinivasan Yegnasubramanian; Xiaohui Lin; Angelo M De Marzo; William G Nelson

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
Journal of cellular biochemistry 2004;91(3):540-52.
151.
2004

Elizabeth A Platz; Angelo M De Marzo; Edward Giovannucci

Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.
Journal of cellular biochemistry 2004;91(3):553-71.
152.
2004

Elizabeth A Platz; Angelo M De Marzo; Edward Giovannucci

Failure to detect prostate cancer in the PSA era: comments on N Engl J Med 2003; 349: 215-224 and N Engl J Med 2003; 349: 335-342.
Cancer causes & control : CCC 2004;15(1):91-4.
153.
2004

Mark L Gonzalgo; Masashi Nakayama; Shing M Lee; Angelo M De Marzo; William G Nelson

Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
Urology 2004;63(2):414-8.
154.
2004

Elizabeth A Platz; Angelo M De Marzo

Epidemiology of inflammation and prostate cancer.
The Journal of urology 2004;171(2 Pt 2):S36-40.
155.
2004

Kurtis E Bachman; Brian G Blair; Keith Brenner; Alberto Bardelli; Sabrina Arena; Shibin Zhou; Jessica Hicks; Angelo M De Marzo; Pedram Argani; Ben Ho Park

p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells.
Cancer biology & therapy 2004;3(2):221-5.
156.
2004

Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; et al.

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(3):811-6.
157.
2004

Alan K Meeker; Angelo M De Marzo

Recent advances in telomere biology: implications for human cancer.
Current opinion in oncology 2004;16(1):32-8.
158.
2004

Hua Zhong; Gregg L Semenza; Jonathan W Simons; Angelo M De Marzo

Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.
Cancer detection and prevention 2004;28(2):88-93.
159.
2003

Angelo M De Marzo; Alan K Meeker; Shan Zha; Jun Luo; Masashi Nakayama; Elizabeth A Platz; William B Isaacs; William G Nelson

Human prostate cancer precursors and pathobiology.
Urology 2003;62(5 Suppl 1):55-62.
160.
2003

Shan Zha; Sacha Ferdinandusse; Simone Denis; Ronald J Wanders; Charles M Ewing; Jun Luo; Angelo M De Marzo; William B Isaacs

Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
Cancer research 2003;63(21):7365-76.
161.
2003

Masashi Nakayama; Christina J Bennett; Jessica L Hicks; Jonathan I Epstein; Elizabeth A Platz; William G Nelson; Angelo M De Marzo

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
The American journal of pathology 2003;163(3):923-33.
162.
2003

Keith E Volmar; Theresa Y Chan; Angelo M De Marzo; Jonathan I Epstein

Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
The American journal of surgical pathology 2003;27(9):1243-52.
163.
2003

Anirban Maitra; N Volkan Adsay; Pedram Argani; Christine Iacobuzio-Donahue; Angelo De Marzo; John L Cameron; Charles J Yeo; Ralph H Hruban

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(9):902-12.
164.
2003

Cristina Magi-Galluzzi; Jun Luo; William B Isaacs; Jessica L Hicks; Angelo M de Marzo; Jonathan I Epstein

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
The American journal of surgical pathology 2003;27(8):1128-33.
165.
2003

William G Nelson; Angelo M De Marzo; William B Isaacs

Prostate cancer.
The New England journal of medicine 2003;349(4):366-81.
166.
2003

Ivan V Litvinov; Angelo M De Marzo; John T Isaacs

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
The Journal of clinical endocrinology and metabolism 2003;88(7):2972-82.
167.
2003

Mark L Gonzalgo; Davi A de Lacerda; Angelo M De Marzo; David Y Chan

Persistent purulent drainage from the glans penis: atypical presentation of pyoderma gangrenosum.
The Journal of urology 2003;169(5):1793-4.
168.
2003

Geert J L H van Leenders; Wesley R Gage; Jessica L Hicks; Bianca van Balken; Tilly W Aalders; Jack A Schalken; Angelo M De Marzo

Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy.
The American journal of pathology 2003;162(5):1529-37.
169.
2003

Angelo M DeMarzo; William G Nelson; William B Isaacs; Jonathan I Epstein

Pathological and molecular aspects of prostate cancer.
Lancet 2003;361(9361):955-64.
170.
2003

S J Collis; G W Ketner; J L Hicks; W G Nelson; A M Demarzo; T L Deweese

Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells.
International journal of radiation biology 2003;79(1):53-60.
171.
2002

Elisabeth I Heath; Theodore L DeWeese; Alan W Partin; Angelo M De Marzo; John D Groopman; William G Nelson; Steven A Piantadosi; Ron Lieberman; Michael A Carducci

The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.
Clinical prostate cancer 2002;1(3):182-7.
172.
2002

Alan K Meeker; Jessica L Hicks; Elizabeth A Platz; Gerrun E March; Christina J Bennett; Michael J Delannoy; Angelo M De Marzo

Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Cancer research 2002;62(22):6405-9.
173.
2002

N Tjarda van Heek; Alan K Meeker; Scott E Kern; Charles J Yeo; Keith D Lillemoe; John L Cameron; G Johan A Offerhaus; Jessica L Hicks; Robb E Wilentz; Michael G Goggins; et al.

Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.
The American journal of pathology 2002;161(5):1541-7.
174.
2002

Guang Yang; Gustavo Ayala; Angelo De Marzo; Weihua Tian; Anna Frolov; Thomas M Wheeler; Timothy C Thompson; J Wade Harper

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3419-26.
175.
2002

Jianfeng Xu; S Lilly Zheng; Akira Komiya; Josyf C Mychaleckyj; Sarah D Isaacs; Jennifer J Hu; David Sterling; Ethan M Lange; Gregory A Hawkins; Aubrey Turner; et al.

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Nature genetics 2002;32(2):321-5.
176.
2002

Markus D Sachs; Katherine A Rauen; Meera Ramamurthy; Jennifer L Dodson; Angelo M De Marzo; Mathew J Putzi; Mark P Schoenberg; Ronald Rodriguez

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
Urology 2002;60(3):531-6.
177.
2002

William Isaacs; Angelo De Marzo; William G Nelson

Focus on prostate cancer.
Cancer cell 2002;2(2):113-6.
178.
2002

Angelo M De Marzo; Helen H Fedor; Wesely R Gage; Mark A Rubin

Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays.
Human pathology 2002;33(7):756-60.
179.
2002

Jun Luo; Shan Zha; Wesley R Gage; Thomas A Dunn; Jessica L Hicks; Christina J Bennett; Charles M Ewing; Elizabeth A Platz; Sacha Ferdinandusse; Ronald J Wanders; et al.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Cancer research 2002;62(8):2220-6.
180.
2002

Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.
The American journal of pathology 2002;160(4):1259-68.
181.
2002

J Carpten; N Nupponen; S Isaacs; R Sood; C Robbins; J Xu; M Faruque; T Moses; C Ewing; E Gillanders; et al.

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Nature genetics 2002;30(2):181-4.
182.
2002

William G Nelson; Theodore L DeWeese; Angelo M DeMarzo

The diet, prostate inflammation, and the development of prostate cancer.
Cancer metastasis reviews 2002;21(1):3-16.
183.
2001

X Lin; K Asgari; M J Putzi; W R Gage; X Yu; B S Cornblatt; A Kumar; S Piantadosi; T L DeWeese; A M De Marzo; et al.

Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Cancer research 2001;61(24):8611-6.
184.
2001

S Zha; W R Gage; J Sauvageot; E A Saria; M J Putzi; C M Ewing; D A Faith; W G Nelson; A M De Marzo; W B Isaacs

Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Cancer research 2001;61(24):8617-23.
185.
2001

W G Nelson; A M De Marzo; T L Deweese; X Lin; J D Brooks; M J Putzi; C P Nelson; J D Groopman; T W Kensler

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
Annals of the New York Academy of Sciences 2001;952():135-44.
186.
2001

X Lin; M Tascilar; W H Lee; W J Vles; B H Lee; R Veeraswamy; K Asgari; D Freije; B van Rees; W R Gage; et al.

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
The American journal of pathology 2001;159(5):1815-26.
187.
2001

T L DeWeese; H van der Poel; S Li; B Mikhak; R Drew; M Goemann; U Hamper; R DeJong; N Detorie; R Rodriguez; et al.

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
Cancer research 2001;61(20):7464-72.
188.
2001

J K Parsons; W R Gage; W G Nelson; A M De Marzo

p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Urology 2001;58(4):619-24.
189.
2001

J K Parsons; C P Nelson; W R Gage; W G Nelson; T W Kensler; A M De Marzo

GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue.
The Prostate 2001;49(1):30-7.
190.
2001

S Manley; N R Mucci; A M De Marzo; M A Rubin

Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
The American journal of pathology 2001;159(3):837-43.
191.
2001

A M De Marzo

In memoriam: Gary J. Miller,MD, PhD.
The Prostate 2001;48(3):128-30.
192.
2001

M J Putzi; A M De Marzo

Prostate pathology: histologic and molecular perspectives.
Hematology/oncology clinics of North America 2001;15(3):407-21.
193.
2001

W G Nelson; A M De Marzo; T L DeWeese

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention.
Urology 2001;57(4 Suppl 1):39-45.
194.
2001

A M De Marzo; M J Putzi; W G Nelson

New concepts in the pathology of prostatic epithelial carcinogenesis.
Urology 2001;57(4 Suppl 1):103-14.
195.
2001

W G Nelson; A M DeMarzo; T L DeWeese

The molecular pathogenesis of prostate cancer: focus on the earliest steps.
European urology 2001;39 Suppl 4():8-11.
196.
2001

C P Nelson; L C Kidd; J Sauvageot; W B Isaacs; A M De Marzo; J D Groopman; W G Nelson; T W Kensler

Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Cancer research 2001;61(1):103-9.
197.
2000

G L David-Beabes; M J Overman; J A Petrofski; P A Campbell; A M de Marzo; W G Nelson

Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
International journal of oncology 2000;17(6):1077-86.
198.
2000

M J Putzi; A M De Marzo

Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia.
Urology 2000;56(5):828-32.
199.
2000

A T Weeraratna; J T Arnold; D J George; A DeMarzo; J T Isaacs

Rational basis for Trk inhibition therapy for prostate cancer.
The Prostate 2000;45(2):140-8.
200.
2000

J C Tchou; X Lin; D Freije; W B Isaacs; J D Brooks; A Rashid; A M De Marzo; Y Kanai; S Hirohashi; W G Nelson

GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
International journal of oncology 2000;16(4):663-76.
201.
2000

S Halachmi; A M DeMarzo; N H Chow; N Halachmi; A E Smith; J F Linn; O Nativ; J I Epstein; M P Schoenberg; D Sidransky

Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin.
European urology 2000;37(3):350-7.
202.
2000

W G Nelson; J W Simons; B Mikhak; J F Chang; A M DeMarzo; M A Carducci; M Kim; C E Weber; A A Baccala; M A Goeman; et al.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.
Cancer chemotherapy and pharmacology 2000;46 Suppl():S67-72.
203.
1999

A M De Marzo; V L Marchi; J I Epstein; W G Nelson

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
The American journal of pathology 1999;155(6):1985-92.
204.
1999

H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
Cancer research 1999;59(22):5830-5.
205.
1999

J W Simons; B Mikhak; J F Chang; A M DeMarzo; M A Carducci; M Lim; C E Weber; A A Baccala; M A Goemann; S M Clift; et al.

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
Cancer research 1999;59(20):5160-8.
206.
1999

A M De Marzo; V L Marchi; E S Yang; R Veeraswamy; X Lin; W G Nelson

Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
Cancer research 1999;59(16):3855-60.
207.
1999

A M De Marzo; B Knudsen; K Chan-Tack; J I Epstein

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
Urology 1999;53(4):707-13.
208.
1999

A M De Marzo; D S Coffey; W G Nelson

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
Urology 1999;53(3 Suppl 3a):29-39; discussion 39-42.
209.
1998

A M De Marzo; W G Nelson; A K Meeker; D S Coffey

Stem cell features of benign and malignant prostate epithelial cells.
The Journal of urology 1998;160(6 Pt 2):2381-92.
210.
1998

A M De Marzo; A K Meeker; J I Epstein; D S Coffey

Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
The American journal of pathology 1998;153(3):911-9.
211.
1998

A M De Marzo; C Bradshaw; J Sauvageot; J I Epstein; G J Miller

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.
The Prostate 1998;34(3):162-8.
212.
1998

S Halachmi; A M De Marzo; J F Linn; J I Epstein; M P Schoenberg

Extensive squamous cell carcinoma in situ of the bladder masking deeply invasive disease.
The Journal of urology 1998;159(1):203.
213.
1998

A Afework; M D Beynon; F Bustamante; S Cho; A Demarzo; R Ferreira; R Miller; M Silberman; J Saltz; A Sussman; et al.

Digital dynamic telepathology--the Virtual Microscope.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 1998;():912-6.
214.
1997

R Ferreira; B Moon; J Humphries; A Sussman; J Saltz; R Miller; A Demarzo

The Virtual Microscope.
Proceedings : a conference of the American Medical Informatics Association / ... AMIA Annual Fall Symposium. AMIA Fall Symposium 1997;():449-53.
215.
1995

D P Edwards; M Altmann; A DeMarzo; Y Zhang; N L Weigel; C A Beck

Progesterone receptor and the mechanism of action of progesterone antagonists.
The Journal of steroid biochemistry and molecular biology 1995;53(1-6):449-58.
216.
1992

A M DeMarzo; S A Oñate; S K Nordeen; D P Edwards

Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
Biochemistry 1992;31(43):10491-501.
217.
1991

K Christensen; P A Estes; S A Oñate; C A Beck; A DeMarzo; M Altmann; B A Lieberman; J St John; S K Nordeen; D P Edwards

Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system.
Molecular endocrinology (Baltimore, Md.) 1991;5(11):1755-70.
218.
1991

D P Edwards; A M DeMarzo; S A Oñate; C A Beck; P A Estes; S K Nordeen

Mechanisms controlling steroid receptor binding to specific DNA sequences.
Steroids 1991;56(5):271-8.
219.
1991

A M DeMarzo; C A Beck; S A Onate; D P Edwards

Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(1):72-6.
220.
1988

G J Miller; A M DeMarzo

Ultrastructural localization of matrix vesicles and alkaline phosphatase in the Swarm rat chondrosarcoma: their role in cartilage calcification.
Bone 1988;9(4):235-41.

Angelo Demarzo The Johns Hopkins University, School of Medicine

Angelo Demarzo

220 Publications

Angelo Demarzo
The Johns Hopkins University, School of Medicine